Jonathan Zenilman, MD
Disclosures: Consulting Fee-Pfizer, Inc.-Other_Role-Chairman of Data Safety Moniitoring Board for Phase 3 vaccine trial - 06/17/2020

Dr. Zenilman is known internationally for his work in infectious disease epidemiology. Prior to coming to Johns Hopkins in 1989, he was a medical epidemiologist at the U.S. Centers for Disease Control (CDC). At Johns Hopkins, he has led major clinical research and teaching programs at the Schools of Medicine and Public Health, and with the Baltimore City Health Department. He was one of the first to apply GIS technology to public health, and his syphilis-mapping project was highlighted in Malcolm Gladwell’s The Tipping Point. In addition to being a productive researcher and clinician, he has been active in health policy, has served as a Senior Medical Advisor for the Office of the Assistant Secretary for Planning and Evaluation (DHHS) 1995-1997, has testified before Congress and the Maryland legislature on infectious diseases related issues.

 

From 2003-19 he was chief of the Division of Infectious Diseases at Johns Hopkins Bayview Medical Center in 2003, where he developed major clinical and research programs in sexually transmitted infections, hospital epidemiology, antibiotic stewardship, skin and soft tissue infections and Phase 1-3 clinical trials  Dr. Zenilman has> 350 publications and is an active teacher, mentoring more than 40 fellows and residents, many who are now in leadership positions

 

Since the onset of COVID, he has worked on vaccine implementation and safety, and is chairperson of the Data Safety Monitoring Committee for the Pfizer COVID vaccine program.  He has consulted on COVID mitigation strategies for schools and public agencies, including the federal courts, and a major hospitality chain

 

He received his B.A. from Cornell University in chemistry and earned his M.D. from State University of New York (SUNY)-Downstate in Brooklyn, NY. He trained at SUNY-Kings County Hospital in internal medicine and did his infectious diseases fellowship at Emory University in Atlanta. He is board-certified in internal medicine and infectious diseases, and is a fellow of the American College of Physicians and of the Infectious Diseases